216 related articles for article (PubMed ID: 36621074)
1. Atypical myelin oligodendrocyte glycoprotein antibody-associated optic neuritis and acute demyelinating polyneuropathy after SARS-CoV-2 infection: Case report and literature review.
Bosello F; Marastoni D; Pizzini FB; Zaffalon C; Zuliani A; Turri G; Mariotto S; Bonacci E; Pedrotti E; Calabrese M
J Neuroimmunol; 2023 Feb; 375():578011. PubMed ID: 36621074
[TBL] [Abstract][Full Text] [Related]
2. SARS-CoV-2-related Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease: A Case Report and Literature Review.
Ide T; Kawanami T; Eriguchi M; Hara H
Intern Med; 2022 Apr; 61(8):1253-1258. PubMed ID: 35135920
[TBL] [Abstract][Full Text] [Related]
3. MOG-IgG positive optic neuritis after SARS-CoV-2 infection.
Gilardi M; Cortese A; Ferraro E; Rispoli M; Sadun R; Altavista MC; Sadun F
Eur J Ophthalmol; 2023 Sep; 33(5):NP87-NP90. PubMed ID: 36317310
[TBL] [Abstract][Full Text] [Related]
4. Myelin oligodendrocyte glycoprotein antibody-associated optic neuritis in a post-COVID-19 infection patient.
Zaini MA; Mohd Zain A; Md Din N; Lam C
Immun Inflamm Dis; 2023 Oct; 11(10):e1051. PubMed ID: 37904693
[TBL] [Abstract][Full Text] [Related]
5. Central nervous system (CNS) inflammatory demyelinating diseases (IDDs) associated with COVID-19: A case series and review.
Feizi P; Sharma K; Pasham SR; Nirwan L; Joseph J; Jaiswal S; Sriwastava S
J Neuroimmunol; 2022 Oct; 371():577939. PubMed ID: 35939945
[TBL] [Abstract][Full Text] [Related]
6. MOG encephalomyelitis after vaccination against severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2): case report and comprehensive review of the literature.
Jarius S; Bieber N; Haas J; Wildemann B
J Neurol; 2022 Oct; 269(10):5198-5212. PubMed ID: 35737110
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of serum MOG antibody and AQP4 antibody in optic neuritis after SARS-CoV-2 infection.
Sun CB
Front Immunol; 2023; 14():1296518. PubMed ID: 38054007
[TBL] [Abstract][Full Text] [Related]
8. MOG-specific T cell response amplified in para- and post-SAR-CoV-2 infection in myelin oligodendrocyte glycoprotein antibody-associated disease.
Wu Q; Thakolwiboon S; Ali AS; Wang Q; Dwyer D; Fox DA; Mao-Draayer Y
J Neuroimmunol; 2023 Sep; 382():578143. PubMed ID: 37467700
[TBL] [Abstract][Full Text] [Related]
9. Optic neuropathies post-Covid 19 - review.
Abdul-Salam State SE; Sfredel V; Mocanu CL; Albu CV; Bălășoiu AT
Rom J Ophthalmol; 2022; 66(4):289-298. PubMed ID: 36589322
[TBL] [Abstract][Full Text] [Related]
10. Myelin oligodendrocyte glycoprotein antibody-associated optic neuritis in a COVID-19 patient: A case report.
Kogure C; Kikushima W; Fukuda Y; Hasebe Y; Takahashi T; Shibuya T; Sakurada Y; Kashiwagi K
Medicine (Baltimore); 2021 May; 100(19):e25865. PubMed ID: 34106635
[TBL] [Abstract][Full Text] [Related]
11. Myelin oligodendrocyte glycoprotein-IgG associated disorders (MOGAD) following SARS-CoV-2 infection: A case series.
Lambe J; McGinley MP; Moss BP; Mao-Draayer Y; Kassa R; Ciotti JR; Mariotto S; Kunchok A
J Neuroimmunol; 2022 Sep; 370():577933. PubMed ID: 35878436
[TBL] [Abstract][Full Text] [Related]
12. SARS-COV-2 a trigger of myelin oligodendrocyte glycoprotein-associated disorder.
Johnsson M; Asztely F; Hejnebo S; Axelsson M; Malmeström C; Olausson T; Lycke J
Ann Clin Transl Neurol; 2022 Aug; 9(8):1296-1301. PubMed ID: 35713508
[TBL] [Abstract][Full Text] [Related]
13. COVID-19-Induced Acute Bilateral Optic Neuritis.
Sawalha K; Adeodokun S; Kamoga GR
J Investig Med High Impact Case Rep; 2020; 8():2324709620976018. PubMed ID: 33238757
[TBL] [Abstract][Full Text] [Related]
14. COVID-19-associated optic neuritis - A case series and review of literature.
Jossy A; Jacob N; Sarkar S; Gokhale T; Kaliaperumal S; Deb AK
Indian J Ophthalmol; 2022 Jan; 70(1):310-316. PubMed ID: 34937266
[TBL] [Abstract][Full Text] [Related]
15. Myelin oligodendrocyte glycoprotein-IgG-associated optic neuritis.
Chun BY; Cestari DM
Curr Opin Ophthalmol; 2018 Nov; 29(6):508-513. PubMed ID: 30281030
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of Myelin Oligodendrocyte Glycoprotein and Aquaporin-4-IgG in Patients in the Optic Neuritis Treatment Trial.
Chen JJ; Tobin WO; Majed M; Jitprapaikulsan J; Fryer JP; Leavitt JA; Flanagan EP; McKeon A; Pittock SJ
JAMA Ophthalmol; 2018 Apr; 136(4):419-422. PubMed ID: 29470571
[TBL] [Abstract][Full Text] [Related]
17. MOG antibody-related disease with recurrent optic neuritis and sensory polyradiculoneuropathy: A case report.
Shima T; Tsujino A
Mult Scler Relat Disord; 2020 Nov; 46():102597. PubMed ID: 33296991
[TBL] [Abstract][Full Text] [Related]
18. Myelin oligodendrocyte glycoprotein antibody-associated optic neuritis and myelitis in COVID-19: a case report and a review of the literature.
Colantonio MA; Nwafor DC; Jaiswal S; Shrestha AK; Elkhooly M; Rollins S; Wen S; Sriwastava S
Egypt J Neurol Psychiatr Neurosurg; 2022; 58(1):62. PubMed ID: 35668818
[TBL] [Abstract][Full Text] [Related]
19. Post COVID-19 Myelin Oligodendrocyte Glycoprotein Antibody-Associated Optic Neuritis.
Rojas-Correa DX; Reche-Sainz JA; Insausti-García A; Calleja-García C; Ferro-Osuna M
Neuroophthalmology; 2022; 46(2):115-121. PubMed ID: 35273416
[TBL] [Abstract][Full Text] [Related]
20. Anti-myelin oligodendrocyte glycoprotein (MOG) antibodies in patients with optic neuritis and seizures.
Gutman JM; Kupersmith M; Galetta S; Kister I
J Neurol Sci; 2018 Apr; 387():170-173. PubMed ID: 29571858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
